Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Dec 10, 2011; 2(12): 384-396
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.384
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.384
Figure 1 Schematic of IL-6 classical and trans-signaling pathway.
IL-6: Interleukin 6; JAK: Janus kinase; MAPK: Mitogen-activated protein kinase; PI3K; Phosphatidylinositol 3-kinase; RANKL: Receptor activator of nuclear factor κB ligand; sIL-6R: Soluble IL-6 receptor; STAT3: Signal transducer and activator of transcription 3.
Figure 2 Hypothetical representation of AR pathway regulation by IL-6 in prostate cancer cells.
IL-6: Interleukin 6; MAPK: Mitogen-activated protein kinase; STAT3: Signal transducer and activator of transcription 3; AR: Androgen receptor; PSA: Prostate-specific antigen.
- Citation: Azevedo A, Cunha V, Teixeira AL, Medeiros R. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2011; 2(12): 384-396
- URL: https://www.wjgnet.com/2218-4333/full/v2/i12/384.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i12.384